Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of intraperitoneal ropivacaine 0.1% for postoperative pain control in gynecologic laparoscopic surgery
2014-002309-39Phase 4Active
- Sponsor
- Osakidetza
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine in postoperative pain, nausea ((none)) and Vomiting, sponsored by Osakidetza. Primary endpoint: Postoperative pain intensity. Started Jun 2015; status: active.
02
Drugs
ropivacaine
03
Conditions
postoperative painnausea ((none))Vomiting
Beyond the preview
Go deeper on 2014-002309-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002309-39.